State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackstone
BX
|
+$692M |
| 2 |
Microsoft
MSFT
|
+$572M |
| 3 |
Palantir
PLTR
|
+$455M |
| 4 |
Equinix
EQIX
|
+$394M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$388M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$6.29B |
| 2 |
Carrier Global
CARR
|
+$945M |
| 3 |
Otis Worldwide
OTIS
|
+$809M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$665M |
| 5 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Financials | 14.6% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
The Bancorp
TBBK
$2.84B
| $61.8M | ﹤0.01% |
2,686,105
+1,077,607
| +67% | +$25.3M |
|
1677
Dr. Reddy's Laboratories
RDY
$10.2B
| $61.8M | ﹤0.01% |
4,203,940
-306,060
| -7% | -$4.28M |
|
1678
Dave & Buster's
PLAY
$357M
| $61.7M | ﹤0.01% |
1,519,420
+47,296
| +3% | +$2.05M |
|
|
MDP
1679
DELISTED
Meredith Corporation
MDP
| $61.6M | ﹤0.01% |
1,417,452
+38,112
| +3% | +$1.35M |
|
|
FSR
1680
DELISTED
Fisker Inc.
FSR
| $61.5M | ﹤0.01% |
3,188,746
+3,101,346
| +3,548% | +$45.8M |
|
1681
Microvision
MVIS
$78.9M
| $61.3M | ﹤0.01% |
244,008
+128,192
| +111% | +$31.6M |
|
1682
MGE Energy Inc
MGEE
$3.08B
| $61.3M | ﹤0.01% |
822,823
+31,213
| +4% | +$2.33M |
|
|
ITCI
1683
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $61.2M | ﹤0.01% |
1,500,029
+16,370
| +1% | +$605K |
|
1684
Vroom Inc
VRM
$48.2M
| $61.2M | ﹤0.01% |
18,277
+3,113
| +21% | +$10.6M |
|
|
GTY
1685
Getty Realty Corp
GTY
$2.07B
| $61.1M | ﹤0.01% |
1,937,380
+84,077
| +5% | +$2.63M |
|
|
VRNT
1686
DELISTED
Verint Systems
VRNT
| $61.1M | ﹤0.01% |
1,354,744
+35,932
| +3% | +$1.67M |
|
1687
Frontdoor
FTDR
$6.26B
| $61M | ﹤0.01% |
1,224,463
+208,957
| +21% | +$11M |
|
1688
Customers Bancorp
CUBI
$2.77B
| $60.9M | ﹤0.01% |
1,560,991
+242,377
| +18% | +$8.73M |
|
|
GTHX
1689
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $60.8M | ﹤0.01% |
2,771,047
+40,111
| +1% | +$891K |
|
1690
Madrigal Pharmaceuticals
MDGL
$11.8B
| $60.6M | ﹤0.01% |
622,462
+36,712
| +6% | +$4.35M |
|
1691
Community Health Systems
CYH
$423M
| $60.6M | ﹤0.01% |
3,923,030
+693,184
| +21% | +$9.42M |
|
1692
TriNet
TNET
$3.14B
| $60.5M | ﹤0.01% |
835,373
+11,117
| +1% | +$862K |
|
1693
First Commonwealth Financial
FCF
$2.17B
| $60.5M | ﹤0.01% |
4,299,936
+225,064
| +6% | +$3.31M |
|
|
AGEN
1694
Agenus
AGEN
$290M
| $60.5M | ﹤0.01% |
561,308
-84,607
| -13% | -$6.34M |
|
|
GBIO
1695
DELISTED
Generation Bio
GBIO
| $60.4M | ﹤0.01% |
224,420
+13,157
| +6% | +$3.94M |
|
|
AGR
1696
DELISTED
Avangrid, Inc.
AGR
| $60.2M | ﹤0.01% |
1,160,623
+176,170
| +18% | +$9.19M |
|
|
MTOR
1697
DELISTED
MERITOR, Inc.
MTOR
| $60.2M | ﹤0.01% |
2,569,036
-21,345
| -0.8% | -$561K |
|
1698
Revolve Group
RVLV
$1.73B
| $60.1M | ﹤0.01% |
872,669
+657,809
| +306% | +$35.3M |
|
1699
Hamilton Lane
HLNE
$5.57B
| $60.1M | ﹤0.01% |
656,786
+64,815
| +11% | +$5.87M |
|
1700
Karyopharm Therapeutics
KPTI
$48M
| $60M | ﹤0.01% |
387,770
+32,285
| +9% | +$4.69M |
|
Similar funds
State Street's Q2 2021 Portfolio in Review
As of Q2 2021, State Street held 4,549 positions worth $1.9T, up 8.8% from $1.74T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
State Street's Q2 2021 filing shows 534 new, 2,776 increased, 937 reduced and 86 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 5,751,234 shares worth $387M. The largest sale was Alibaba, an estimated $6.29B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q2 2021 buy was Vanguard FTSE Europe ETF: 5,751,234 shares worth $387M.
- State Street added most to Blackstone in Q2 2021, an estimated $692M increase.
- State Street's biggest Q2 2021 reduction was Alibaba, cutting an estimated $6.29B.
- State Street fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $665M.
- State Street's ten largest holdings make up 21% of its $1.9T portfolio in Q2 2021.
- State Street opened 534 new positions and closed 86 in Q2 2021.
- State Street's portfolio value rose 8.8% quarter-over-quarter to $1.9T.
Based on State Street's 13F filing for Q2 2021, filed 16 Aug 2021.